05:38 PM EDT, 08/14/2024 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Wednesday it closed its initial public offering of 2.8 million shares at $8 apiece, raising about $22.4 million for the clinical-stage biopharmaceutical company.

The firm said it has granted a 30-day option to its underwriters to buy up to 420,000 additional shares to cover over-allotments.

The shares started trading on Nasdaq on Tuesday.

Price: 10.00, Change: +0.85, Percent Change: +9.29